Insmed | INSM - Trade Creditors

Stock Price
156.24
Daily Change
3.80 2.49%
Monthly
-10.76%
Yearly
93.41%
Q1 Forecast
152.04

Insmed reported $79.59M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
DBV Technologies USD 39.82M 972K Sep/2025
Dynavax Technologies USD 3.95M 1.25M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Insmed USD 79.59M 1.24M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025